Binghot, Resselmae D.

HRN: 29-27-09  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/04/2026
AMPICILLIN 1GM (VIAL)
07/04/2026
07/11/2026
IV
2g
Q6
PROM
Checking Initial Appropriateness 

 Indication:  Empiric    Type of Infection:  Reproductive Tract    Compliance to guidelines: Compliant To Guidelines